ProShares Ultra Nasdaq Biotechnology (BIB) Options

50.12 ↓0.21 (-0.42%)
As of April 24, 2024, 3:59pm EST.

BIB Max Pain

The max pain for BIB on March 20th, 2026 is $35.

ProShares Ultra Nasdaq Biotechnology is currently $50.12 which is 43.20% higher than its max pain. According to the max pain theory, ProShares Ultra Nasdaq Biotechnology will likely gravitate lower closer to $35 by March 20th.

Outlook: Negative

BIB Max Pain Distribution Chart

Your browser does not support this chart.

Option Chain

The option chain for ProShares Ultra Nasdaq Biotechnology on March 20th.

Calls

StrikeLast PriceBreakevenBidAskVolumeOpen InterestIVDeltaGammaThetaVegaTheoretical Value
Loading option chain data... this might take a few seconds.

Puts

StrikeLast PriceBreakevenBidAskVolumeOpen InterestIVDeltaGammaThetaVegaTheoretical Value
Loading option chain data... this might take a few seconds.
Updated as of market close on December 22nd

Discussions

Please log in or register to share your thoughts.

iburnmoney

$BIB Markets about as efficient as a retirement home

0 Like Report
MyNameIsDraven

$BIB do what the markets tells you to do not the other way around

0 Like Report
SayMyName

$BIB this market love evrry dips let’s see

0 Like Report
a

$BIB GET IN mofos!!!

0 Like Report